PRIA Logo™
119-hr-10787119th CongressWALLET

Access to Medical Supplies Act

Sponsored By: Representative Murphy, Gregory F. [R-NC-3]

Introduced

Summary

Pauses inclusion of urological and ostomy supplies in Medicare's competitive acquisition program for five years starting January 1, 2028. It also requires an expert panel and a small demonstration project to study how those supplies should be purchased while protecting patient access and choice.

Show full summary
  • Patients and caregivers would keep a right to the same or clinically comparable supplies during the pause and could buy from another supplier if the same supplies are not available. Contract suppliers would be barred from steering patients to change brands.
  • The Secretary would create a Technical Expert Panel of at least 15 members drawn from patients, clinicians, suppliers, manufacturers, and reimbursement and medical-necessity experts. The panel must review stakeholder input and literature, recommend administration and bid levels, and make meeting minutes and related documents public on the Centers for Medicare & Medicaid Services (CMS) website.
  • A Demonstration Project would run in no more than three states for 12 months and must begin within three years of enactment. The project requires a pre-demonstration survey and a follow-up survey within three months to measure continued access and feed recommendations from the expert panel.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

Protections for Medicare supply users

If enacted, the bill would exclude urological and ostomy supplies from Medicare’s competitive acquisition program for supplies furnished on or after January 1, 2028 and before January 1, 2033. The Secretary would set up a technical expert panel within 90 days, with at least 15 members and recommendations due within one year. Within three years of enactment the Secretary would run a 12-month demonstration in up to three States. CMS would survey a sample of users before the demonstration and resurvey them within three months after it starts. Contract suppliers would be prohibited from pressuring or steering patients to change brands or from giving unsolicited brand information. If you cannot get the same or a clinically comparable product under a demonstration or program, you would be allowed to obtain it from another supplier, including a non-contract supplier. Panel minutes and related documents would be posted on the CMS website.

Sponsors & CoSponsors

Sponsor

Murphy, Gregory F. [R-NC-3]

NC • R

Cosponsors

  • Rep. Schneider, Bradley Scott [D-IL-10]

    IL • D

    Sponsored 10/9/2026

  • Rep. Meuser, Daniel [R-PA-9]

    PA • R

    Sponsored 10/29/2026

  • Rep. Pingree, Chellie [D-ME-1]

    ME • D

    Sponsored 10/22/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation